These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 20509034

  • 1. Serum levels of proamylin and amylin in normal subjects and patients with impaired glucose regulation and type 2 diabetes mellitus.
    Zheng X, Ren W, Zhang S, Liu J, Li S, Li J, Yang P, He J, Su S, Li P.
    Acta Diabetol; 2010 Sep; 47(3):265-70. PubMed ID: 20509034
    [Abstract] [Full Text] [Related]

  • 2. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes.
    Pan HY, Guo L, Li Q.
    Diabetes Res Clin Pract; 2010 Apr; 88(1):29-33. PubMed ID: 20129687
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y, Lu JM, Sun JF, Li CL, Wang XL, Zhang XQ, Lü ZH, Dou JT, Mu YM.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 17; 89(10):669-72. PubMed ID: 19595059
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
    da Silva RC, Miranda WL, Chacra AR, Dib SA.
    J Diabetes Complications; 2007 Mar 17; 21(2):84-92. PubMed ID: 17331856
    [Abstract] [Full Text] [Related]

  • 7. Circulating obestatin levels in normal subjects and in patients with impaired glucose regulation and type 2 diabetes mellitus.
    Qi X, Li L, Yang G, Liu J, Li K, Tang Y, Liou H, Boden G.
    Clin Endocrinol (Oxf); 2007 Apr 17; 66(4):593-7. PubMed ID: 17371480
    [Abstract] [Full Text] [Related]

  • 8. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E, Menschikowski M, Koehler C, Leonhardt W, Hanefeld M.
    Metabolism; 2005 Sep 17; 54(9):1168-73. PubMed ID: 16125528
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Association of serum uric acid with different levels of glucose and related factors.
    Yuan HJ, Yang XG, Shi XY, Tian R, Zhao ZG.
    Chin Med J (Engl); 2011 May 17; 124(10):1443-8. PubMed ID: 21740795
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Estimating intraday blood glucose variability through self-monitoring of blood glucose in people with impaired glucose tolerance and type 2 diabetes].
    Lü LF, Wang C, Liu GJ, Chen DW, Chen LH, Li YH, Zhou J, Jia WP, Ran XW.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan 17; 42(1):95-100. PubMed ID: 21355311
    [Abstract] [Full Text] [Related]

  • 18. The impact of family history of type 2 diabetes on pancreatic beta-cell function.
    Wang ZH, Zhang SH, Gong LL, Ren W, Li R, Zheng RZ, Zhang YF, Wang MR, Li QF.
    Diabetes Res Clin Pract; 2009 Oct 17; 86(1):61-6. PubMed ID: 19674808
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.